These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4977259)

  • 1. [Competitive enzyme mechanisms in the therapy of hemoblastosis using antimetabolites].
    Wilmanns W
    Verh Dtsch Ges Inn Med; 1968; 74():822-30. PubMed ID: 4977259
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimetabolites.
    Allegra CJ; Baram J; Chabner BA; Yeh GC; Aiba K; Curt GA
    Cancer Chemother Biol Response Modif; 1987; 9():1-22. PubMed ID: 2484324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antimetabolites].
    Wilmanns W
    Internist (Berl); 1971; 12():Suppl 1:127-35. PubMed ID: 4944750
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy and comparative biochemistry: G. H. A. Clowes memorial lecture.
    Hitchings GH
    Cancer Res; 1969 Nov; 29(11):1895-903. PubMed ID: 4982548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antimetabolites in the treatment of acute human leukoses. Mechanism of action and conditioning factors in the cellular response to drugs. II].
    Grignani F; Martelli M; Tonato M
    Clin Ter; 1974 Apr; 69(2):153-76. PubMed ID: 4134598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possible applications of antivitamins and antimetabolites in therapy].
    Frick PG
    Bibl Nutr Dieta; 1966; 8():6-16. PubMed ID: 5950495
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative sensitivity to various antimetabolites of several established cell lines derived from the buffy coat of normal humans and patients with neoplastic diseases.
    Aoki Y; Moore GE
    Cancer Res; 1969 Jun; 29(6):1307-12. PubMed ID: 5256298
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimetabolites in the therapy of acute human leukoses. Mechanism of action and conditioning factors in the cellular response to drugs. I].
    Grignani F; Martelli M; Tonato M
    Clin Ter; 1974 Apr; 69(1):67-86. PubMed ID: 4525082
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic side-effects of allopurinol.
    O'Sullivan WJ
    Prog Biochem Pharmacol; 1974; 9():174-93. PubMed ID: 4140532
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the effects of several inhibitors of the synthesis of nucleic acids upon the viability and progression through the cell cycle of cultured H. Ep. no. 2 cells.
    Wheeler GP; Bowdon BJ; Adamson DJ; Vail MH
    Cancer Res; 1972 Dec; 32(12):2661-9. PubMed ID: 4264728
    [No Abstract]   [Full Text] [Related]  

  • 11. [Regulation of purine metabolism and its modification by drugs].
    Müller MM; Kaiser E
    Dtsch Med Wochenschr; 1975 Jan; 100(5):198-204. PubMed ID: 1112235
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytostatic therapy of hemoblastosis].
    Ehrhart H
    Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of antimetabolites on kinetic behavior of proliferating cultured L1210 leukemia cells.
    Wilkoff LJ; Wilcox WS; Burdeshaw JA; Dixon GJ; Dulmadge EA
    J Natl Cancer Inst; 1967 Nov; 39(5):965-75. PubMed ID: 6071005
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
    van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
    Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimetabolites.
    Chu E; Johnston PG; Grem JL; Takimoto CH; Van Groeningen C; Chabner BA; Allegra CJ
    Cancer Chemother Biol Response Modif; 1994; 15():1-31. PubMed ID: 7779582
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental study of radiosensitizing effect of analogs of purines and pyrimidine bases in cultured HeLa cells].
    Pavlov AS; Kostromina KN; Parkhomenko IM; Simakina EP; Han Youngsoo
    Vestn Ross Akad Med Nauk; 2001; (8):48-51. PubMed ID: 11552626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimetabolites.
    Chu E; Grem JL; Johnston PG; Politi PM; Chabner BA; Allegra CJ
    Cancer Chemother Biol Response Modif; 1992; 13():1-30. PubMed ID: 1389906
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunodepressants (review of the literature)].
    Uteshev BS; Kovalev IE
    Farmakol Toksikol; 1967; 30(3):361-72. PubMed ID: 4876661
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzyme activities and deoxynucleoside utilization of leukemic leukocytes in relation to drug therapy and resistance.
    Roberts D; Hall TC
    Cancer Res; 1969 Jan; 29(1):166-73. PubMed ID: 5249740
    [No Abstract]   [Full Text] [Related]  

  • 20. [Causes of the preferential action of imuran on the viability and proliferative activity of a Chinese hamster cell culture in the stationary growth phase].
    Makarova GF; Epifanova OI; Loginov BV
    Tsitologiia; 1980 Nov; 22(11):1339-45. PubMed ID: 6893772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.